Basis of Presentation - Narrative (Details) $ in Thousands |
1 Months Ended | 3 Months Ended | 6 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Feb. 13, 2019
element
|
Mar. 31, 2023
USD ($)
|
Jun. 29, 2024
USD ($)
|
Jul. 01, 2023
USD ($)
|
Jun. 29, 2024
USD ($)
|
Jul. 01, 2023
USD ($)
|
Mar. 30, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Apr. 01, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
|
| Business Acquisition [Line Items] | ||||||||||
| Allowance for doubtful accounts | $ 1,495 | $ 1,725 | $ 1,495 | $ 1,725 | $ 8,596 | $ 9,193 | $ 2,265 | $ 2,630 | ||
| Research and development expense | $ 14,200 | $ 12,700 | $ 27,500 | $ 25,400 | ||||||
| Non-Aerospace Contract Manufacturing Customer | ||||||||||
| Business Acquisition [Line Items] | ||||||||||
| Allowance for doubtful accounts | $ 7,500 | |||||||||
| Sold | Semiconductor Test Business | Test Systems Segment | ||||||||||
| Business Acquisition [Line Items] | ||||||||||
| Number of elements for contingent earnouts | element | 2 | |||||||||
| Earnout proceeds received | $ 3,400 | |||||||||
| X | ||||||||||
- Definition Disposal Group, Including Discontinued Operation, Contingent Consideration Received No definition available.
|
| X | ||||||||||
- Definition Number Of Elements For Contingent Earn-Outs No definition available.
|
| X | ||||||||||
- Definition Amount of allowance for credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|